ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: UBLITUXIMAB (BRIUMVI).
Awarded
The competition has ended and a winner has been selected.
- Award
- Price only
- Procedure
- Without prior noticeTwo stages
- Agreement
- Buying goodsover 6 months
Brief
El Servicio Madrileño de Salud, Hospital Universitario La Paz, ha adjudicado un contrato a NEURAXPHARM SPAIN S.L. para el suministro de productos farmacéuticos, específicamente el medicamento exclusivo UBLITUXIMAB (BRIUMVI), con entrega en Madrid y Barcelona. El contrato tiene una duración de 6 meses y un valor final de 215.941 €. Se recibió una oferta para esta licitación.
Farmasøytisk engroshandel
Result
- NEURAXPHARM SPAIN S.L.Winner
- 1Number of tenders received
- €215,941Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Coste
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Servicio Madrileño de Salud - Hospital Universitario La Paz
From the notice
ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: UBLITUXIMAB (BRIUMVI).
Contact
contratacion.hulp@salud.madrid.org- Result · PrequalificationType
- Madrid, BarcelonaLocation
- 33600000Main codePharmaceutical products